Magnolia Bark
Also known as: Magnolia officinalis, houpo, magnolia bark extract, MBE, honokiol, magnolol
Effective Dosage
No established dose from provided studies for systemic use; oral health products used ~0.84 mg per tablet or 0.15% by weight in gum
What the Science Says
Magnolia bark is the dried bark of Magnolia officinalis, used for centuries in traditional East Asian medicine. Its best-supported use is in oral health: clinical trials show that chewing gum or tablets containing magnolia bark extract (combined with zinc) significantly reduce the sulfur compounds that cause bad breath for up to two hours, and 30-day use reduced cavity-causing bacteria and gum bleeding. Its active compounds honokiol and magnolol have shown anti-inflammatory and antioxidant effects in animal and cell studies, but human evidence for these broader benefits is very limited.
What It Doesn't Do
Won't reliably treat anxiety or insomnia on its own — the one clinical study combined it with isoflavones and probiotics, so you can't credit magnolia bark alone. No human evidence it fights cancer, despite promising lab results. Not proven to protect your heart in humans. Don't expect it to replace your toothbrush or mouthwash for long-term oral health.
Evidence-Based Benefits
The strongest clinical evidence supports magnolia bark extract (combined with zinc) reducing oral volatile sulfur compounds (bad breath) for up to two hours in double-blind RCTs (PMID: 26054178, PMID: 23210417). A 30-day RCT found magnolia bark chewing gum reduced salivary mutans streptococci, plaque acidogenicity, and gingival bleeding compared to control (PMID: 21822018). In a clinical trial of menopausal women, magnolia bark extract added to isoflavones showed greater improvement in anxiety, irritability, insomnia, and mood compared to isoflavones alone (PMID: 21311416).
Weak EvidenceEffective at: No established dose from provided studies for systemic use; oral health products used ~0.84 mg MBE per tablet or 0.15% by weight in gum
Source: auto-research
Absorption & Bioavailability
Poor in standard form. The active compounds honokiol and magnolol have low water solubility and poor oral absorption. Nanoemulsion delivery systems improved bioavailability 3–8x in animal studies, but standard supplement capsules likely deliver much less.
Red Flags to Watch For
- Magnolia bark contains higenamine and its precursor coclaurine — higenamine is banned by WADA, posing a real doping violation risk for competitive athletes
- Most exciting benefits (anti-cancer, cardioprotection, lung fibrosis) come from animal or cell studies only — do not assume these translate to humans
- Clinical studies on anxiety and sleep used magnolia bark in combination products, making it impossible to isolate its individual effect
- Poor natural bioavailability means standard supplement doses may deliver far less active compound than used in research
- No standardized human dosing established — products vary widely in honokiol/magnolol content
Products Containing Magnolia Bark
See how Magnolia Bark is used in these analyzed products:
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06